source
- Aurora Therapeutics drops PKU program and trims staffAurora Therapeutics, a gene-editing startup founded by Jennifer Doudna, announced it is abandoning its lead phenylketonuria (PKU) program. The decision follows growing competition in the PKU field…
- Novo Nordisk shares slide 6% after Wegovy pill sales miss despite earnings beatNovo Nordisk reported second‑quarter results that beat both revenue and profit forecasts, posting a profit of $5.15 billion. The company’s oral Wegovy obesity pill generated $496 million in sales,…